Factors Affecting the Decline in Incidence of Diabetes in the Diabetes Prevention Program Outcomes Study (DPPOS)
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
During the first 7 years of the Diabetes Prevention Program Outcomes Study (DPPOS), diabetes incidence rates, when compared with the Diabetes Prevention Program (DPP), decreased in the placebo (−42%) and metformin (−25%), groups compared with the rates in the intensive lifestyle intervention (+31%) group. Participants in the placebo and metformin groups were offered group intensive lifestyle intervention prior to entering the DPPOS. The following two hypotheses were explored to explain the rate differences: “effective intervention” (changes in weight and other factors due to intensive lifestyle intervention) and “exhaustion of susceptible” (changes in mean genetic and diabetes risk scores). No combination of behavioral risk factors (weight, physical activity, diet, smoking, and antidepressant or statin use) explained the lower DPPOS rates of diabetes progression in the placebo and metformin groups, whereas weight gain was the factor associated with higher rates of progression in the intensive lifestyle intervention group. Different patterns in the average genetic risk score over time were consistent with exhaustion of susceptibles. Results were consistent with exhaustion of susceptibles for the change in incidence rates, but not the availability of intensive lifestyle intervention to all persons before the beginning of the DPPOS. Thus, effective intervention did not explain the lower diabetes rates in the DPPOS among subjects in the placebo and metformin groups compared with those in the DPP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Although they may apply only to persons meeting the DPP eligibility criteria of BMI and fasting and 2-hour post-load glucose, DPP participants represent a substantial fraction of the US adult population.”
From Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial (2025) · cites this paper as [19]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Based on US data from 2007–2016, an estimated 10∙7% of non-diabetic adults aged 20–64 years and 30∙2% of those aged ≥65 years would meet the DPP eligibility criteria.19”
From Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial (2025) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Self-citationTuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Self-citationStatins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436 · cited 1×
“Finally, we explored a series of other risk factors that predict diabetes (15) and might have differed by treatment group, including changes in waist circumference (model 8), other aspects of diet (model 9), alcohol consumption (model 10) (16), smoking status (model 11) (17), use of antidepressants (model 12), depress…”
BackgroundLi, G., Zhang, P., Wang, J., Gregg, E. W., Yang, W., Gong, Q., Li, H., Li, H., Jiang, Y., An, Y., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60766-7 · Cited by 1,600 · cited 1×
“Studies reviewed included the long-term follow-up of Pima Indians with IGT (24), the Finnish Diabetes Prevention Study (14), the DREAM (25,26) and DREAM-ON follow-up studies (27), the Da Qing Prevention Study (28), and the ADDITION-Denmark study (29).”
BackgroundEffect of weight loss with lifestyle intervention on risk of diabetes
Hamman, R. F., Wing, R. R., Edelstein, S. L., Lachin, J. M., Bray, G. A., Delahanty, L., Hoskin, M., Kriska, A. M., Mayer-Davis, E. J., Pi-Sunyer, X., et al. (2006) · Diabetes Care · doi:10.2337/dc06-0560 · Cited by 1,344
Self-citationA collection of Physical Activity Questionnaires for health-related research.
Pereira, M. A., FitzerGerald, S. J., Gregg, E. W., JOSWIAK, M. L., Ryan, W. J., Suminski, R. R., Utter, A. C., & Zmuda, J. M. (1997) · PubMed · Cited by 1,051
Ridker, P. M., Pradhan, A., MacFadyen, J. G., Libby, P., & Glynn, R. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61190-8 · Cited by 816 · cited 1×
“Finally, we explored a series of other risk factors that predict diabetes (15) and might have differed by treatment group, including changes in waist circumference (model 8), other aspects of diet (model 9), alcohol consumption (model 10) (16), smoking status (model 11) (17), use of antidepressants (model 12), depress…”
BackgroundEffect of ramipril on the incidence of diabetes
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa065061 · Cited by 737
Edelstein, S. L., Knowler, W. C., Bain, R. P., Andres, R., Barrett-Connor, E. L., Dowse, G. K., Haffher, S. M., Pettitt, D. J., Sorkin, J. D., Muller, D. C., et al. (1997) · Diabetes · doi:10.2337/diab.46.4.701 · Cited by 641 · cited 2×
“Men, n (%) 888 (32) 291 (32) 307 (33) 290 (31)”
BackgroundSelf-citationKNOWLER, W. C., BENNETT, P. H., HAMMAN, R. F., & MILLER, M. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112648 · Cited by 601 · cited 1×
“50 years of age among the Pima Indians, together with a possible cohort effect, where older cohorts were less exposed to risk earlier in life (23).”
BackgroundSelf-citation(DPS), F. T. F. D. P. S., Lindström, J., Peltonen, M., Eriksson, J. G., Ilanne-Parikka, P., Aunola, S., Keinänen-Kiukaanniemi, S., Uusitupa, M., & Tuomilehto, J. (2013) · Diabetologia · doi:10.1007/s00125-012-2752-5 · Cited by 551
Introduction to a Collection of Physical Activity Questionnaires
Kriska, A. M., & Caspersen, C. J. (1997) · Medicine& Science in Sports & Exercise · doi:10.1097/00005768-199706001-00003 · Cited by 446 · cited 2×
“Goals were defined annually for the weight goal (#7% weight loss), exercise goal ($150 min/week of moderate physical activity [$6 MET-h/week, based on the Modified Activity Questionnaire]), and the fat intake goal (total dietary fat,25% of calories).”
MethodThe natural history of impaired glucose tolerance in the Pima Indians
Saad, M. F., Knowler, W. C., Pettitt, D. J., Nelson, R. G., Mott, D. M., & Bennett, P. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812083192302 · Cited by 413 · cited 10×
“Participants were $25 years of age and overweight or obese, and had impaired glucose tolerance (IGT) and elevated fasting glucose levels (5).”
BackgroundInfluentialSelf-citationMozaffarian, D., Kamineni, A., Carnethon, M., Djoussé, L., Mukamal, K. J., & Siscovick, D. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.21 · Cited by 358 · cited 1×
“Finally, we explored a series of other risk factors that predict diabetes (15) and might have differed by treatment group, including changes in waist circumference (model 8), other aspects of diet (model 9), alcohol consumption (model 10) (16), smoking status (model 11) (17), use of antidepressants (model 12), depress…”
BackgroundSmoking as a Modifiable Risk Factor for Type 2 Diabetes in Middle-Aged Men
Wannamethee, S. G., Shaper, A. G., & Perry, I. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1590 · Cited by 314
Validity and Reproducibility of a Food Frequency Interview in a Multi-Cultural Epidemiologic Study
Mayer-Davis, E. J., Vitolins, M. Z., Carmichael, S. L., Hemphill, S., Tsaroucha, G., Rushing, J., & Levin, S. (1999) · Annals of Epidemiology · doi:10.1016/s1047-2797(98)00070-2 · Cited by 300 · cited 1×
“In addition, dietary intake data were collected by the modified Block Food Frequency Questionnaire (8) at regular intervals.”
MethodBiostatistical methods : the assessment of relative risks
Lachin, J. M. (2000) · Cited by 272
Self-citationWinkelstein, W., Samuel, M., Padian, N. S., Wiley, J. A., Lang, W., Anderson, R. E., & Levy, J. A. (1987) · American Journal of Public Health · doi:10.2105/ajph.77.6.685 · Cited by 264 · cited 1×
“This concept has a long history in the explanation of infectious disease transmission (21) and has been invoked to explain incidence patterns in selected cancers (22).”
BackgroundRubin, R. R., Ma, Y., Marrero, D. G., Peyrot, M., Barrett-Connor, E. L., Kahn, S. E., Haffner, S. M., Price, D. W., Knowler, W. C., & for the Diabetes Prevention Program Research Group (2008) · Diabetes Care · doi:10.2337/dc07-1827 · Cited by 242
Self-citationThe Diabetes Prevention Program Research Group (2003) · Diabetes Care · doi:10.2337/diacare.26.4.977 · Cited by 218
Biostatistical Methods: The Assessment of Relative Risks
Lachin, J. M. (2000) · Wiley Series in Probability and Statistics · doi:10.1002/9780470317051 · Cited by 200
Self-citationHivert, M.-F., Jablonski, K. A., Perreault, L., Saxena, R., McAteer, J. B., Franks, P. W., Hamman, R. F., Kahn, S. E., Haffner, S., the DIAGRAM Consortium, et al. (2011) · Diabetes · doi:10.2337/db10-1119 · Cited by 191
Self-citationRasmussen, S. S., Glümer, C., Sandbæk, A., Lauritzen, T., & Borch‐Johnsen, K. (2007) · Diabetologia · doi:10.1007/s00125-007-0893-8 · Cited by 102 · cited 10×
“Participants were $25 years of age and overweight or obese, and had impaired glucose tolerance (IGT) and elevated fasting glucose levels (5).”
BackgroundResultInfluentialThe Diabetes Prevention Program Research Group, Venditti, E. M., Bray, G. A., Carrion-Petersen, M. L., Delahanty, L. M., Edelstein, S. L., Hamman, R. F., Hoskin, M. A., Knowler, W. C., & Ma., Y. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.134 · Cited by 93
Self-citationAlssema, M., Vistisen, D., Heymans, M. W., Nijpels, G., Glümer, C., Zimmet, P., Shaw, J. E., Eliasson, M., Stehouwer, C. D. A., Tabák, Á. G., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1990-7 · Cited by 85
Byrne, C. D., Wareham, N. J., Brown, D. C., CLARK, P. M. S., Cox, L., Day, N., Palmer, C., Wang, T. W. M., Williams, D. R. R., & Hales, C. N. (1994) · Diabetologia · doi:10.1007/bf00400944 · Cited by 84 · cited 1×
“Risk Factors Variables in this analysis included demographic factors; obesity measures (weight in kilograms), height (in meters), waist circumference (in centimeters), BMI (in kilograms per square meter); measures of glycemia (fasting and 2-h glucose levels, and A1C percentage); and insulin sensitivity (1/fasting insu…”
MethodAlcohol consumption and diabetes risk in the Diabetes Prevention Program
Crandall, J. P., Polsky, S., Howard, A. A., Perreault, L., Bray, G. A., Barrett-Connor, E. L., Brown-Friday, J., Whittington, T., Foo, S. T., Ma, Y., et al. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27382 · Cited by 65
Self-citationLong-term effect of rosiglitazone and/or ramipril on the incidence of diabetes
DREAM On (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication Ongoing Follow-up) Investigators (2011) · Diabetologia · doi:10.1007/s00125-010-1985-4 · Cited by 54 · cited 1×
“Studies reviewed included the long-term follow-up of Pima Indians with IGT (24), the Finnish Diabetes Prevention Study (14), the DREAM (25,26) and DREAM-ON follow-up studies (27), the Da Qing Prevention Study (28), and the ADDITION-Denmark study (29).”
BackgroundFrailty modelling of testicular cancer incidence using Scandinavian data
Moger, T. A., Aalen, O. O., Halvorsen, T. O., Storm, H. H., & Tretli, S. (2004) · Biostatistics · doi:10.1093/biostatistics/5.1.1 · Cited by 28 · cited 1×
“This concept has a long history in the explanation of infectious disease transmission (21) and has been invoked to explain incidence patterns in selected cancers (22).”
Background
Cited by
(2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00291-0 · Cited by 1,029
Prevention of Type 2 Diabetes by Lifestyle Changes: A Systematic Review and Meta-Analysis
Uusitupa, M., Khan, T. A., Viguiliouk, E., Kahleova, H., Rivellese, A. A., Hermansen, K., Pfeiffer, A., Thanopoulou, A., Salas-Salvadó, J., Schwab, U., et al. (2019) · Nutrients · doi:10.3390/nu11112611 · Cited by 465
Hemmingsen, B., Gimenez-Perez, G., Mauricio, D., Roqué i Figuls, M., Metzendorf, M.-I., & Richter, B. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003054.pub4 · Cited by 316
Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention
Hostalek, U., Gwilt, M., & Hildemann, S. (2015) · Drugs · doi:10.1007/s40265-015-0416-8 · Cited by 278
“diabetes incidence in the other groups [85].”
for the Diabetes Prevention Program Research Group, Aroda, V. R., Knowler, W. C., Crandall, J. P., Perreault, L., Edelstein, S. L., Jeffries, S. L., Molitch, M. E., Pi-Sunyer, X., Darwin, C., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4361-9 · Cited by 194
Self-citation
Metadata
- Authors
- Diabetes Prevention Program (DPP) Research Group, Hamman, R. F., Horton, E., Barrett-Connor, E., Bray, G. A., Christophi, C. A., Crandall, J., Florez, J. C., Fowler, S., Goldberg, R., Kahn, S. E., Knowler, W. C., Lachin, J. M., Murphy, M. B., & Venditti, E.
- Affiliations
- Colorado School of Public Health (US)
- Joslin Diabetes Center (US)
- University of California San Diego (US)
- Pennington Biomedical Research Center (US)
- George Washington University (US)
- Albert Einstein College of Medicine (US)
- Massachusetts General Hospital, Boston, MA
- University of Miami (US)
- University of Washington (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- University of Tennessee Health Science Center (US)
- University of Pittsburgh Medical Center (US)
- Corresponding author
- Hamman, Richard F.
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-10-01
- Volume
- 64
- Issue
- 3
- Pages
- 989-998
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC4338587
- OpenAlex
- W1926199670
- Cited by
- 46
- References
- 35
- Citations by year
- 2025: 4 · 2023: 3 · 2022: 5 · 2021: 2 · 2020: 5 · 2019: 4 · 2018: 2 · 2017: 10 · 2016: 3 · 2015: 6
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NIH Clinical Center (U01 DK048489)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes incidence, Diabetes Prevention Program Outcomes Study, Diabetes Prevention Program, metformin, intensive lifestyle intervention, weight gain, polygenic risk score, behavioral risk factors, diabetes prevention, type 2 diabetes
- MeSH terms
- Aged, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Male, Metformin, Middle Aged, Risk Factors, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.